Correction : Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced non-small cell lung cancer: the PUMA trial (Radiation Oncology, (2023), 18, 1, (74), 10.1186/s13014-023-02258-9) (2023) Regnery S, de Colle C, Eze C, Corradini S, Thieke C, Sedlaczek O, Schlemmer HP, et al. Journal article, Erratum Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis (2023) Boldrini L, Romano A, Chiloiro G, Corradini S, De Luca V, Verusio V, D’Aviero A, et al. Journal article Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy (2023) Stechele M, Link H, Hirner-Eppeneder H, Alunni-Fabbroni M, Wildgruber M, Salvermoser L, Corradini S, et al. Journal article Comparison of adverse events in partial- or whole breast radiotherapy: investigation of cosmesis, toxicities and quality of life in a meta-analysis of randomized trials (2023) Haussmann J, Budach W, Corradini S, Krug D, Jazmati D, Tamaskovics B, Bölke E, et al. Journal article Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study (2023) Klaar R, Rabe M, Gaass T, Schneider MJ, Benlala I, Eze C, Corradini S, et al. Journal article Deep learning based automatic segmentation of organs-at-risk for 0.35 T MRgRT of lung tumors (2023) Ribeiro MF, Marschner S, Kawula M, Rabe M, Corradini S, Belka C, Riboldi M, et al. Journal article Plan robustness analysis for threshold determination of SGRT-based intrafraction motion control in 3DCRT breast cancer radiation therapy (2023) Sauer TO, Stillkrieg W, Ott O, Fietkau R, Bert C Journal article Chromosomal radiosensitivity in oncological and non-oncological patients with rheumatoid arthritis and connective tissue diseases (2023) Rzepka D, Schenker H, Geinitz H, Silberberger E, Kaudewitz D, Schuster B, Kuhlmann L, et al. Journal article MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial (2022) Hoegen P, Zhang KS, Tonndorf-Martini E, Weykamp F, Regnery S, Naumann P, Lang K, et al. Journal article 18F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy (2022) Wiltgen T, Fleischmann DF, Kaiser L, Holzgreve A, Corradini S, Landry G, Ingrisch M, et al. Journal article